Blood Cancer Journal (BCJ) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Nature Publishing. and its abbreviation is Blood Cancer J.
The latest Impact Factor of the Blood Cancer Journal for 2026-2027 is 12.8.
The Publication fees (APC) is $4790, £3290, €3790.
Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field.
Topics of particular interest include, but are not limited to, the following:
Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.
| Journal title | Blood Cancer Journal (BCJ) |
| Abbreviation | Blood Cancer J |
| Online ISSN | 2044-5385 |
| Publisher Name | Nature Publishing |
| Editor-in-chief | Dr Ayalew Tefferi |
| Subject Category | Medicine |
| Access type | 🟢 Open Access |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Blood Cancer Journal
| Impact Factor | 12.8 |
| SJR | 3.699 |
| SNIP | 2.436 |
| Ranking | 426 |
| CiteScore | 13.4 |
| H-Index | 68 |
| Quartile | Q1 |
| Article Publication Charges (APC) |
$4790, £3290, €3790 ✳️Without APC Medicine Journals |
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
| Abstracting and Indexing |
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
Add the app to your device for one-tap access.